U.K. Dx firm launches massive glucose test strip recall; Do surgeons perform too many heart stent angioplasties?;

@FierceMedDev: UPDATED: Bard ordered to pay $2M in vaginal mesh trial defeat. News | Follow @FierceMedDev

@DamianFierce: A global cybersecurity outfit is lending a hand to the medical device industry. Article | Follow @DamianFierce

@MarkHFierce: Heathrow Airport have been warned that female terrorists might strike with breast implant explosives. Report | Follow @MarkHFierce

@MichaelGFierce: ICYMI: St. Jude nets FDA approval for low-radiation ablation catheters. Article | Follow @MichaelGFierce

> Menarini Diagnostics is recalling more than 1.7 million of its GlucoMen LX Sensor blood glucose test strips in the U.K., warning of inaccurate test results. Article

> Cardica ($CRDC) has filed for FDA clearance for its MicroCutter Xchange cutting and stapling device. News

> San Diego's Genalyte has launched a Type 1 diabetes assay that measures 7 autoantibodies associated with the destruction of pancreatic islet cells. Release

> The in vitro diagnostics market will reach $1.1 billion by 2018, Transparency Market Research concludes in a new report. Item

> Ortho Kinematics gained 510(k) clearance to expand the use of its vertebral motion diagnostic device to neck assessments, beyond the lumbar spine. Item

> Heart stent angioplasties are among the 5 most overused medical procedures, two major groups have concluded. Blog (sub. req.)

Biotech News

@FierceBiotech: We're looking for the fiercest women in biotech for our 2013 report. Editor's note | Nomination form | Follow @FierceBiotech

@JohnCFierce: MannKind rewarded for positive Afrezza data with $40M financing. Report | Follow @JohnCFierce

@RyanMFierce: Scientists found a causal link between a tooth cavity bacterium and colon cancer in mice, potential drug target. More from TheScientist | Follow @RyanMFierce

@EmilyMFierce: SeattleBioMed wins $16M NIH grant for tuberculosis research. ICYMI yesterday from FierceBiotechResearch.com | Follow @EmilyMFierce

> Shkreli's biotech Retrophin zeroes in on $25M financing with 'major' pharma deal looming. Article

> Epizyme picks up FDA orphan nod for lead cancer drug as going public pays off. News

> Ophthotech eyes $85M IPO to fund PhIII for drug to prevent blindness. Report

Pharma News

@FiercePharma: Trending online: Which are pharma's top 4 innovators? Hint: It's not the big guys. More | Follow @FiercePharma

@EricPFierce: FDA wants help figuring out how to stop addicts from getting to the APIs in opioid painkillers. Story from FiercePharmaManufacturing.com | Follow @EricPFierce

@CarlyHFierce: The latest in India vs. Big Pharma IP developments: Roche won't pursue Herceptin patents in India. Article | Follow @CarlyHFierce

> NICE denies Pfizer lung cancer drug in final guidance. Report

> Stada quickly pulls off deal for OTC maker Thorton & Ross. Article

> Easing U.S. drug spending gives Sanofi, Novo room to raise insulin prices. Story

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.